Advisors Preferred, LLC Calliditas Therapeutics Ab Transaction History

Advisors Preferred, LLC

  • $645 Million
  • Q3 2024

A detailed history of Advisors Preferred, LLC transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Advisors Preferred, LLC holds 2,022 shares of CALT stock, worth $80,880. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,022
Holding current value
$80,880
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
BUY
$38.0 - $41.55 $76,836 - $84,014
2,022 New
2,022 $80,000

Others Institutions Holding CALT

# of Institutions
4
Shares Held
4.17K
Call Options Held
0
Put Options Held
0
View Full List

About Calliditas Therapeutics AB

CALT Quotes by TradingView
  • Ticker CALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,624,800
  • Market Cap $1.06B
  • Description
  • Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...
More about CALT
Track This Portfolio

Track Advisors Preferred, LLC Portfolio

Follow Advisors Preferred, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Preferred, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Preferred, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email